Q2 2026
Read transcript →Arvinas, Inc. (ARVN) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$8.62
-1.15%
Mkt Cap $561.98M
Q1 2026
Read transcript →Q4 2025
Read transcript →Q3 2025
Read transcript →Q2 2025
Read transcript →Q1 2025
Read transcript →Q4 2024
Read transcript →Q3 2024
Read transcript →